Mirae Asset Global Etfs Holdings Ltd. Nuvation Bio Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 73,215 shares of NUVB stock, worth $212,323. This represents 0.0% of its overall portfolio holdings.
Number of Shares
73,215Holding current value
$212,323% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NUVB
# of Institutions
151Shares Held
123MCall Options Held
9.7KPut Options Held
6.5K-
Eco R1 Capital, LLC San Francisco, CA19.2MShares$55.7 Million1.98% of portfolio
-
Black Rock Inc. New York, NY16.2MShares$47.1 Million0.0% of portfolio
-
Omega Fund Management, LLC Boston, MA13.3MShares$38.5 Million50.57% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$29.4 Million0.0% of portfolio
-
Decheng Capital LLC Menlo Park, CA6.95MShares$20.2 Million6.22% of portfolio
About Nuvation Bio Inc.
- Ticker NUVB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 217,244,000
- Market Cap $630M
- Description
- Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...